Answers are grounded in this paper and cite their sources.
Sjögren’s disease (SjD) is characterized by progressive damage to the salivary and lacrimal glands as a core pathological hallmark. The loss of acinar cells and the decline in secretory function represent the key drivers of irreversible disease progression. Accumulating evidence indicates that multiple forms of programmed cell death (PCD), including pyroptosis, ferroptosis, apoptosis, and necroptosis, collectively contribute to glandular damage in SjD, rather than a single pathway being solely responsible. This review systematically synthesizes the independent evidence for these four PCD modalities and, drawing on the synergistic logic of classical PANoptosis, proposes an expanded interactive network model of PCD. In this hypothesized model, interferon-gamma (IFN-γ) and reactive oxygen species (ROS) may serve as candidate signaling molecules linking pyroptosis and ferroptosis within a proposed core interactive axis; however, direct causal evidence in SjD-specific models is currently lacking. Aquaporin-5 (AQP5) may function as a potential local modulating factor, negatively regulated by both inflammatory signals and lipid ROS, thereby potentially contributing to a localized self-amplifying loop characterized by “AQP5 downregulation triggering ROS accumulation, which in turn activates PCD and exacerbates the spread of injury.” However, current evidence for this AQP5-related axis is derived mainly from a single dry eye model, and its role in SjD remains to be established. Apoptosis and necroptosis act as potential synergistic factors, indirectly enhancing the pathogenic effects of the proposed core loop through the release of damage-associated molecular patterns (DAMPs). Based on this hypothesized framework, we propose exploratory stratified therapeutic strategies that may target candidate nodes, including IFN-γ, the Janus kinase-signal transducer and activator of transcription (JAK-STAT) pathway, ROS, the NOD-like receptor family pyrin domain-containing 3 (NLRP3) inflammasome, and glutathione peroxidase 4 (GPX4), to interrupt this positive feedback, alongside exploring gene repair or organoid-based regenerative approaches to restore AQP5 function. Due to the low level of evidence, apoptosis and necroptosis are not currently prioritized as core intervention targets, and their potential synergistic value warrants further investigation. This model may provide a hypothesis-generating framework for understanding progressive glandular damage in SjD; however, all core hypotheses warrant direct validation using animal models and human histological specimens. Future investigations should prioritize mechanistic confirmation and clinical translation.
No takes yet. Share an insight, caveat, or question.
Zou et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: